Document is current
Any future updates will be listed below
-
Authors
Szinyei, Anna Zsófia https://orcid.org/0009-0006-9539-4795
Maus, Bastian https://orcid.org/0000-0003-1872-9097
Schmid, Jonas Q. https://orcid.org/0000-0002-6990-2657
Klimek, Matthias https://orcid.org/0009-0002-5257-288X
Segelcke, Daniel https://orcid.org/0000-0002-4405-2596
Pogatzki-Zahn, Esther M. https://orcid.org/0000-0003-0981-3940
Pradier, Bruno https://orcid.org/0000-0001-9792-6042
Faber, Cornelius https://orcid.org/0000-0001-7683-7710
-
Funding
Funding for this research was provided by:
Universität Münster
- License Information
-
More Information
Article History
Received: 11 October 2024
Revised: 25 November 2024
Accepted: 9 December 2024
First Online: 15 January 2025
Declarations
:
: EPZ has received payments from Grünenthal (Germany), MSD Sharp & Dohme GmbH (Germany), and Medtronic (UK) for advisory board activities and lecture fees. EPZ has received funding for research from the Gemeinsamer Bundesausschuß (GBA), the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777500 (this Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA), Grünenthal Germany, the DFG and the BMBF. All payments were made to the institution, EPZ is working for (UKM), and not for herself. The other authors declare no conflict of interests.
